<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-vaccines-07-00168">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Black</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shinefield</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Baxter</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Austrian</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Bracken</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hansen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Fireman</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente</article-title>
  <source>Pediatr. Infect. Dis. J.</source>
  <year>2004</year>
  <volume>23</volume>
  <fpage>485</fpage>
  <lpage>489</lpage>
  <pub-id pub-id-type="doi">10.1097/01.inf.0000129685.04847.94</pub-id>
  <?supplied-pmid 15194827?>
  <pub-id pub-id-type="pmid">15194827</pub-id>
 </element-citation>
</ref>
